Skip to main content
Log in

Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) Gene Associated with Treatment Response to Mood Stabilizers in Patients with Bipolar I Disorder

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

There is increasing evidence supporting the relationship between bipolar disorder (BP) and neurotrophin. The present study investigated the relationship between neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene polymorphisms and bipolar I disorder (BP I) susceptibility and treatment response to mood stabilizers (lithium or valproate). Two-hundred eighty-four patients who met the DSM-IV criteria for BP I and 295 matched healthy controls were enrolled into this study. TaqMan® SNP genotyping assays were applied to genotype three NTRK2 gene polymorphisms (rs2769605, rs1565445, rs1387923). Our study showed a significant allelic association between NTRK2 gene polymorphism rs2769605 and treatment response to mood stabilizers in BP I patients (t = −2.53, P = 0.01). However, no significant association between NTRK2 gene polymorphisms and BP I susceptibility was observed after correcting for multiple comparisons. The results suggest that the NTRK2 gene polymorphism likely plays an essential role in treatment response to mood stabilizers in Han Chinese BP I patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bremer T, Diamond C, McKinney R et al (2007) The pharmacogenetics of lithium response depends upon clinical co-morbidity. Mol Diagn Ther 11:161–170

    Article  PubMed  CAS  Google Scholar 

  • Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A et al (2008) Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics 9:1595–1603

    Article  PubMed  CAS  Google Scholar 

  • Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT (2009) Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res 43:1175–1184

    Article  PubMed  CAS  Google Scholar 

  • Einat H, Manji HK (2006) Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59:1160–1171

    Article  PubMed  CAS  Google Scholar 

  • Fan J, Sklar P (2008) Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp 289:60–72

    Article  PubMed  CAS  Google Scholar 

  • Farmer A, Elkin A, McGuffin P (2007) The genetics of bipolar affective disorder. Curr Opin Psychiatry 20:8–12

    Article  PubMed  Google Scholar 

  • First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV axis I disorders, patient version. American Psychiatric Press, Washington DC

    Google Scholar 

  • Gao K, Calabrese JR (2005) Newer treatment studies for bipolar depression. Bipolar Disorders 7(suppl 5):13–23

    Google Scholar 

  • Garnham J, Munro A, Slaney C et al (2007) Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord 104:185–190

    Article  PubMed  Google Scholar 

  • Grof P, Duffy A, Cavazzoni P et al (2002) Is response to prophylactic lithium a familial trait? J Clin Psychiatry 63:942–947

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto K, Shimizu E, Iyo M (2004) Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45:104–114

    Article  PubMed  CAS  Google Scholar 

  • Hayden EP, Nurnberger JI Jr (2006) Molecular genetics of bipolar disorder. Genes Brain Behav 5:85–95

    PubMed  CAS  Google Scholar 

  • Hosang GM, Uher R, Keers R et al (2010) Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 125:345–349

    Article  PubMed  CAS  Google Scholar 

  • Kremeyer B, Herzberg I, Garcia J et al (2006) Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate. Am J Med Genet B Neuropsychiatr Genet 141B:435–439

    Article  PubMed  CAS  Google Scholar 

  • Luberg K, Wong J, Weickert CS, Timmusk T (2010) Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem 113:952–964

    Article  PubMed  CAS  Google Scholar 

  • Murphy ML, Carballedo A, Fagan AJ et al (2012) Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder. Biol Psychiatry 72:663–670

    Article  PubMed  CAS  Google Scholar 

  • Petryshen TL, Sabeti PC, Aldinger KA et al (2010) Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry 15:810–815

    Article  PubMed  CAS  Google Scholar 

  • Rybakowski JK, Czerski P, Dmitrzak-Weglarz M et al (2012) Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol 26:368–373

    Article  PubMed  CAS  Google Scholar 

  • Shaltiel G, Chen G, Manji HK (2007) Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 7:22–26

    Article  PubMed  CAS  Google Scholar 

  • Smith EN, Bloss CS, Badner JA et al (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14:755–763

    Article  PubMed  CAS  Google Scholar 

  • Smoller JW, Finn CT (2003) Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 123C:48–58

    Article  PubMed  Google Scholar 

  • Thompson Ray M, Weickert CS, Wyatt E, Webster MJ (2011) Decreased BDNF, trkB-TK + and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36:195–203

    Article  PubMed  Google Scholar 

  • Vinberg M, Trajkovska V, Bennike B, Knorr U, Knudsen GM, Kessing LV (2009) The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology 34:1380–1389

    Article  PubMed  CAS  Google Scholar 

  • Xu J, Liu Y, Wang P et al (2010) Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet B Neuropsychiatr Genet 153B:275–279

    PubMed  Google Scholar 

  • Zandi PP, Judy JT (2010) The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am 33:181–224

    Article  PubMed  Google Scholar 

  • Zarate CA Jr, Singh J, Manji HK (2006) Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006–1020

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Funding for this study was provided by the National Natural Science Foundation of China (grant no. 30971047), Shanghai Jiaotong University School of Medicine Training Program for Excellent Doctoral Dissertation (grant no. YBPY2010010), Shanghai Key Medicine Specialties Program (grant no. ZK2012A12), Key Medicine Specialties Program of Hongkou District (grant no. Hongkou Health [2010]91) and Hongkou District Medicine Study Program (grant no. Hongkou Health 1101-02). Partial support was received from the “12th Five-year Plan” of the National Key Technologies R&D Program (2012BAI01B04) and the National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH2011-873). The authors thank Joseph R. Calabrese from Case Western Reserve University School of Medicine and Martin Alda from Dalhousie University for the permission of using the scale “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorders.” The authors also express their gratitude to Mrs. Mary Beth Serrano from Case Western Reserve University for grammatical assistance.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zuowei Wang or Yiru Fang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Z., Fan, J., Gao, K. et al. Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) Gene Associated with Treatment Response to Mood Stabilizers in Patients with Bipolar I Disorder. J Mol Neurosci 50, 305–310 (2013). https://doi.org/10.1007/s12031-013-9956-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-013-9956-0

Keywords

Navigation